Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any Alzheimer disease in which the cause of the disease is a mutation in the PLD3 gene.
1 clinical trial registered. Interventions under study include medical devices. Pipeline includes 1 NA. Research is primarily industry-sponsored.
3 publications have been identified in PubMed for Alzheimer disease 19. Research spans Epidemiology / Natural History (67%) and Review / Meta-Analysis (33%).
Mattiuzzi C (2025). [PMID: 39487371](https://pubmed.ncbi.nlm.nih.gov/39487371/). *European geriatric medicine*. [Epidemiology / Natural History]
Roh JH (2024). [PMID: 38806183](https://pubmed.ncbi.nlm.nih.gov/38806183/). *QJM : monthly journal of the Association of Physicians*. [Epidemiology / Natural History]
Pszczołowska M (2024). [PMID: 38977629](https://pubmed.ncbi.nlm.nih.gov/38977629/). *GeroScience*. [Review / Meta-Analysis]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 8:52 AM UTC
Online Mendelian Inheritance in Man
Common questions about Alzheimer disease 19